Who we serve.

Contribute independent clinical insight to the evaluation of emerging cardiovascular technologies and, where appropriate, participate in separately structured investment opportunities.

Capital, candid physician assessment, and help positioning the company for the buyer most likely to acquire it.

Deal-by-deal SPV syndication into cardiovascular companies our physician network has already evaluated.

An external view of physician-validated cardiovascular companies as they become relevant to your portfolio.